Keratin 76 (Krt76) is expressed in the differentiated epithelial layers of skin, oral cavity and squamous stomach. Krt76 downregulation in human oral squamous cell carcinomas (OSCC) correlates with poor prognosis. We show that genetic ablation of Krt76 in mice leads to spleen and lymph node enlargement, an increase in regulatory T cells (Tregs) and high levels of proinflammatory cytokines. Krt76 -/-Tregs have increased suppressive ability correlated with increased CD39 and CD73 expression, while their effector T cells are less proliferative than controls. Loss of Krt76 increases carcinogen-induced tumours in tongue and squamous stomach. Carcinogenesis is further increased when Treg levels are elevated experimentally. The carcinogenesis response includes upregulation of pro-inflammatory cytokines and enhanced accumulation of Tregs in the tumour microenvironment. Tregs also accumulate in human OSCC exhibiting Krt76 loss. Our study highlights the role of epithelial cells in modulating carcinogenesis via communication with cells of the immune system.
INTRODUCTION
Keratins, the intermediate filament proteins of epithelial cells, are essential for normal tissue function, acting as a scaffold that enables cells to resist stress and damage 1 . Mutations that impair keratin assembly have been identified in a range of human skin disorders, typically leading to skin blistering or abnormal differentiation 2 . Recent studies have highlighted a novel role for keratins as regulators of inflammation and immunity in epithelia [3] [4] [5] [6] [7] [8] .
Krt76 is a type II intermediate filament protein expressed in the differentiating, non-proliferative layers of a subset of stratified epithelia in human and mouse 9 . Krt76 is the most significantly downregulated gene encoding a structural protein in human oral squamous cell carcinoma (OSCC) and correlates strongly with poor prognosis 10 . OSCC arises from the multilayered epithelial lining of the mouth and the lips. It involves mostly the tongue, but can also occur in the floor of the mouth, gingiva, lip, cheek and palate. Despite advances in treatment, the 5 year survival rate for OSCC remains stubbornly low, at 50-60% 11 .
In patients, KRT76 is detected in 100% of normal gingivobuccal epithelial biopsies, 44% of oral preneoplastic lesions and 35% of OSCC 10 . However, Krt76-null mice do not develop spontaneous OSCC, indicating that loss of Krt76 alone is not sufficient to induce tumours 10 .
Nonetheless, genetic ablation of Krt76 in mice results in skin barrier defects, epidermal hyperproliferation and inflammation 12, 13 , with mild hyperplasia and keratinization of the buccal epithelium 10 .
Here we have investigated the role of Krt76 in oral and stomach epithelial homeostasis and the response of those tissues to the chemical carcinogen 4-nitroquinoline N-oxide (4NQO) 14 , which mimics the carcinogenic effects of tobacco and alcohol ingestion 15 . We provide evidence for a previously unidentified role of Krt76 in regulating immunity in mice and demonstrate its importance in tumour progression.
RESULTS

Keratin 76 is expressed in oral epithelia and stomach
To analyse Krt76 expression and function, we used Krt76 mutant mice (Krt76 tm1a(KOMP)Wtsi ) generated by the Wellcome Trust Sanger Institute (WTSI) Mouse Genetics Project 13, 16, 17 (Figure   1a ). As a result of splicing of the lacZ trapping element to Krt76 exon 2, homozygous mice do not express Krt76 (Krt76 -/-). Heterozygous mice (Krt76 +/-), expressing one copy of Krt76 and one copy of the lacZ reporter under the control of the endogenous promoter, were used to visualize Krt76 expression in the oral cavity and stomach. Krt76 was first expressed at embryonic day 17.5 (E17.5) in the tongue, palate and stomach (Figure 1b Mouse stomach contains two well-defined areas: the non-glandular forestomach (also known as squamous stomach, which connects to the oesophagus) and the glandular stomach. Krt76 expression was confined to the suprabasal layers of the squamous stomach ( Figure 1h ).
Expression of Krt76 was further confirmed by antibody labelling (Figure 1c , i) and qRT-PCR ( Figure 1j ).
Loss of Krt76 results in enlargement of the lymph nodes and spleen without affecting epithelial homeostasis in the oral cavity and forestomach
Although it was previously reported that loss of Krt76 results in hyperplasia of the buccal epithelium 10 , we observed no histological abnormalities in the tongue or forestomach and no obvious changes in epithelial proliferation in Krt76 -/-mice, as assessed by EdU labelling (Figure   2a -c). However, between the ages of 4 and 8 months all Krt76 -/-mice spontaneously developed a large cyst (up to 17mm in diameter) between the lower jaw and the forelimbs (Figure 2d -f). Each cyst was filled with fluid and was juxtaposed to the salivary gland ( Figure 2g ).
Immunofluorescence staining for B220 (CD45R) and CD3 revealed the presence of B and T cells, respectively, establishing that the cysts were enlarged submandibular lymph nodes ( Figure   2h , i). Flow cytometric analysis of the lymphocyte populations confirmed that the cyst cells were CD4 + or CD8 + mature T-cells ( Figure 2j ). Compared with the heterozygous controls (Krt76 +/-), the lymph nodes in other body sites were also increased in size ( Figure 2k ), even though Krt76 was not expressed in control lymph nodes ( Supplementary Fig. 1a-b ). Consistent with the increased size of the lymph nodes, there was a 2.2-to 3.9-fold increase in the absolute number of mesenteric, submandibular, axillary and inguinal lymph node cells in Krt76 -/-mice compared with heterozygous littermate controls ( Figure 2l ).
No changes were observed in thymus size or cellularity (Figure 2m -o). However, Krt76 -/-mice had enlarged spleens, with a 2.2-fold increase in the number of cells in the spleen (Figure 2p -r).
In addition, adult Krt76 -/-mice consistently weighed less than control mice ( Figure 2s ).
We conclude that loss of Krt76 results in splenomegaly and lymphadenopathy, indicative of systemic inflammation.
Krt76 -/-mice show increased local and circulating effector and regulatory T cells and inflammatory cytokines
To dissect the inflammatory phenotype of Krt76 -/-mice, flow cytometric analysis of immune cell populations was performed. The percentage of total lymphocytes that were B cells (B220 + TCRβ -) was increased in Krt76 -/-mouse lymph nodes ( Supplementary Fig. 1c -d) compared to heterozygous controls. The percentage of T cells (TCRβ + CD3 + CD4 + ) that were effector T cells (CD4 + CD44 high CD62L low ) was significantly increased in the spleen and lymph nodes ( Figure 3a ).
Effector T cells are known to play an important role in anti-tumour immunity 18 . There was also a significant increase in regulatory T cells (Tregs; TCRβ + CD4 + CD3 + Foxp3 + 19 ) in the lymph nodes and thymus of Krt76 -/-mice, but not in the spleen (Figure 3b ). Tregs are potent antiinflammatory cells that, among other functions, impede the anti-tumour immune response in a variety of cancers 20 .
The changes in the levels of T effector cells, Tregs and B cells correlated with a striking upregulation of circulating IL-6, IL-10, and TNFα ( Figure 3c ). The fluid inside the lymphoid cysts of Krt76 -/-mice also had significantly elevated IL-6, IL-10 and TNFα (Figure 3d ). The levels of IFNγ, IL-2 and IL-4 were not altered ( Figure 3c ). TNFα is known to stimulate Treg expansion 21 .
To examine whether loss of Krt76 also resulted in local inflammation, we measured cytokine mRNA levels in the tongue and squamous stomach. This revealed a significant upregulation of TNFα in the tongue and IL-4 and TSLP in the squamous stomach ( Figure 3e ). Consistent with these local increases in cytokine production, the total immune cell infiltrate (total CD45 + cells) was significantly increased in the tongue and squamous stomach when compared to heterozygous controls (Figure 3f , g). We also confirmed the previously reported increase in the skin inflammatory infiltrate 12, 13 (Figure 3f , g).
Taken together, these data demonstrate that loss of Krt76 results in local and systemic inflammation.
Functional differences between Krt76 -/-and control Tregs and T effector cells
To discover whether the functionality of Tregs and T effector cells differed in Krt76 -/-and control mice we performed in vitro suppression assays (Figure 4 ; Supplementary Fig. 2 ). Tregs were isolated from the spleen of control and Krt76 -/-mice and co-cultured at different ratios with CFSE-labelled CD4 + CD25 -responder T cells, which include the T effector population (Tresp). The suppression of proliferation was measured by flow cytometry (Figure 4a, b ). Krt76 -/-Tregs inhibited Tresp proliferation more effectively than control Tregs, whether the Tresp were from control ( Figure 4b ) or Krt76 -/-mice ( Supplementary Fig. 2a ). In addition, the proliferative activity of Krt76 -/-Tresp in the absence of Tregs was lower than that of control Tresp ( Figure   4c ).
The higher suppressive capacity of Krt76 -/-Tregs correlated with increased capacity to inhibit expression of the pro-inflammatory cytokines IFNγ and IL17 and the anti-inflammatory cytokine IL-10, whether the Tresp cells were from control ( Figure 4d ) or Krt76 -/-mice ( Supplementary   Fig. 2b ). Tregs from Krt76 -/-mice expressed higher levels of the Treg suppressive markers CD39 and CD73 compared to control Tregs (Figure 4e , f). CD39 + Tregs are known to suppress T cell proliferation and inflammatory cytokine production more efficiently than CD39 Tregs 22 . The differences between the properties of Tregs from Krt76 -/-and control mice did not reflect a difference in Foxp3 expression levels ( Figure 4g ).
We conclude that Tregs from Krt76 -/-mice have enhanced suppressive function and Tresp are less proliferative compared with cells from control mice.
Increased tumour incidence in Krt76 -/-mice
To determine whether the loss of Krt76 directly impacts tumour incidence in the oral cavity, we treated control (wild-type Krt76 +/+ and heterozygous Krt76 +/-) and Krt76 -/-mice with a synthetic carcinogen 4NQO 14 (Figure 5a ) that mimics the carcinogenic effects of tobacco and alcohol ingestion 15 . In wild-type mice 4NQO induces carcinoma in the oral cavity and oesophagus, but not in the remainder of the digestive tract 23 . Mice received 100µg/ml of 4NQO in the drinking water for 16 weeks and were monitored for the appearance and progression of lesions for a total of 28 weeks ( Figure 5a ). Hyperplasia of the dorsal tongue was evident by 6 weeks and from 10 weeks mice had raised localised white lesions corresponding to dysplasias (Figure 5a To explore the significance of the downregulation of Krt76 that occurs in human oral squamous cell carcinomas (OSCC) 10 , we monitored changes in the expression of Krt76 by LacZ labelling in 4NQO-treated Krt76 +/-mice. Krt76 downregulation was first observed in hyperplastic oral epithelium ( Figure 5d ; 13 out of 15 mice), consistent with the findings in human patients 10 . 10 out of 13 dysplasias and 4 out of 4 invasive SCC had focal or total loss of Krt76 (Figure 5d , arrowed). Nevertheless, even when tumours developed within the same mouse, some lesions had lost Krt76 expression whereas others retained it ( Figure 5d , I and II). This was confirmed with immunostaining for Krt76; as expected ( Figure 1 , Supplementary Fig. 3d ), Krt76, when present, was co-expressed with differentiation markers such as Loricrin ( Figure 5e ).
We next compared the incidence of oral cavity tumours in Krt76 +/+ , Krt76 +/-and Krt76 -/-mice ( Figure 5f ). There was no significant difference between Krt76 +/+ and Krt76 +/-mice; however, Krt76 -/-mice developed OSCC earlier. In Krt76 -/-mice, the average onset of lesions was at 12 weeks after treatment (n=16), compared to 17 weeks in control mice (n=14 Krt76 +/+ and n=27 Krt76 +/-, p<0.0001). Furthermore, in Krt76 -/-mice the incidence was 100% by 14 weeks (Figure   5f We conclude that Krt76 ablation accelerates 4NQO-induced tumour progression in the tissues where Krt76 is expressed, namely the oral cavity and squamous stomach.
Tumour incidence in Krt76 -/-mice is not linked to defective epithelial barrier formation
It has previously been reported that Krt76 -/-epidermis exhibits reduced expression of tight junction proteins, Claudins, and an increase in the number of suprabasal layers 12, 13 ( Supplementary Fig. 3f ). In contrast there was no reduction in Claudin1, Claudin3 or Claudin7 expression in Krt76 -/-tongue or stomach epithelium ( Supplementary Fig. 3f ). There was no difference in the total thickness of tongue and stomach epithelium between control and Krt76 -/mice, nor in the suprabasal (Loricrin, Filaggrin or Involucrin-positive) layers ( Supplementary Fig.  3d , e), although by Q-PCR a reduction in Involucrin was observed in Krt76 -/-stomach ( Supplementary Fig. 3f ).
The epithelial integrity of the oral epithelia of Krt76 -/-mice was assessed by a whole-mount Toluidine Blue dye penetration assay 24 and was found not to be defective ( Supplementary Fig.   3b ). Furthermore, following introduction of FITC-dextran by oral gavage there were no differences in the concentration of FITC-dextran in blood serum between control and Krt76 -/mice ( Supplementary Fig. 3c ). The previously reported delay in epidermal barrier formation 12 was confirmed ( Supplementary Fig. 3a ).
To examine whether there was increased penetration of commensal microorganisms that could lead to an activation of immune cells, we measured the bacterial load of the tongue and stomach epithelia by Gram staining and performed whole-mount fluorescence in situ hybridization (FISH) with a universal bacterial probe (BacUni) 25 . Bacterial penetration was largely confined to the cornified layers of the tongue filiform papillae in both Krt76 -/-and control mice, demonstrating that there was no significant difference in bacterial load or penetration ( Supplementary Fig. 3g -h).
We conclude that loss of Krt76 did not compromise the integrity and barrier properties of tongue and stomach epithelia.
Krt76 -/-mice exhibit an exacerbated local and inflammatory response to carcinogen treatment
Since Krt76 -/-mice exhibit local and systemic inflammation, we examined whether this was exacerbated by 4NQO treatment. Tongue and squamous stomach were collected after 2 weeks of 4NQO treatment to assess whether the levels of inflammatory cytokines were altered. The levels of cytokines were increased upon 4NQO treatment of both Krt76 +/-control and Krt76 -/-mice compared to untreated mice (Figure 6a compared to Figure 3c ). However, blood serum levels of IFNγ, IL-4, IL-6, IL-10 and TNFα were significantly higher in 4NQO treated Krt76 -/-than control mice (Figure 6a ).
In the tongue there were significantly more stromal CD45 + cells in Krt76 -/-versus control mice prior to 4NQO treatment (Figure 3f , g), following 2 weeks of treatment and in 4NQO-induced hyperplasias (Figure 6b , arrowheads, 6c). In Krt76 -/-stomach, the number of local CD45 + cells increased in the stroma adjacent to 4NQO-induced tumours (Figure 6d ).
Immunofluorescence labelling for Foxp3 revealed an increase of Tregs in both tongue and squamous stomach of Krt76 -/-mice compared to control mice, whether normal or tumourbearing tissue (Figure 6e -h). The number of Tregs increased in hyperplasias and dysplasias of Krt76 -/-tongue compared to controls and there was a marked accumulation of Tregs in tumour stroma (Figure 6e , g, arrowheads, h). Furthermore, lesions in Krt76 -/-tongue and stomach presented a concomitant decrease in effector T cells ( Figure 6i ). Total CD4 + cells were increased in the stomach but not in the tongue (Figure 6i ). Consistent with the findings in mice, there was an increase in stromal FoxP3 + cells underlying Krt76-negativeregions of human OSCC ( Figure   7a ) even when the differentiation marker Involucrin was still expressed (Figure 7b ).
Two cytokines that control Tregs are IL-18, which regulates Treg function 26, 27 , and IL-33, which is constitutively expressed in barrier epithelial cells 28, 29 and promotes Treg accumulation and maintenance in inflamed tissues 30 . Consistent with the accumulation of Tregs, IL-18 levels were significantly increased in 4NQO treated (2 weeks) Krt76 -/-compared to Krt76 +/-tongue ( Figure   6j ). In addition, IL-33 was increased in Krt76 -/-tongue and squamous stomach after 4NQO treatment ( Figure 6j ).
We conclude that the increased cancer susceptibility of Krt76 -/-mice is correlated with an exacerbated systemic and inflammatory response to carcinogen, including the accumulation of Tregs in the tongue and squamous stomach.
Increase in Tregs correlates with accelerated tumour formation in Krt76 -/-mice
To examine whether targeting Tregs influences tumour onset in Krt76 -/-mice, we developed (Figure 8c ). However, when all the mice in each cohort had developed tumours and were subjected to end-point analysis, the total number of Tregs was significantly increased in DT-treated compared to PBS-treated DEREG/Krt76 -/-mice ( Figure   8d ). In control DEREG/Krt76 +/+ mice, the increase in lymph node Tregs following DT treatment was not statistically significant ( Figure 8d ). However, in the spleen of DT-treated DEREG/Krt76 +/+ mice there was a significant increase in Tregs (Figure 8e ). Further analysis of Krt76 -/-chimeras ( Figure 8f ) showed that while, as expected, donor GFP + Tregs were reduced there was a significant increase in recipient GFP -Tregs, accounting for the increase in total Tregs.
Quantitation of 4NQO-induced carcinogenesis revealed that DT treatment accelerated tumour formation in both control and Krt76 -/-mice ( Figure 8g ). Thus higher levels of Foxp3 + Tregs correlate with more rapid tumour development in both control and Krt76 -/-mice. The major effect of Krt76 deletion on tumour susceptibility may therefore be via enhanced accumulation of Tregs.
DISCUSSION
Stratified, terminally differentiated epithelia, such as epidermis and oral epithelium, provide protective barriers against the environment, and their function depends on structural proteins, such as keratins. Until recently, keratins were mainly regarded as cytoskeletal scaffolds; however, there is an emerging role for keratins in the regulation of epidermal immunity [3] [4] [5] [6] 8, 32, 33 . For example, Krt1 is not only crucial to maintain skin integrity, but also regulates innate immunity by restricting IL-18 release from keratinocytes 5 . Krt17 acts as a regulator of skin immune responses and loss of Krt17 promotes reduced cell proliferation, leading to a delay in skin tumour onset 6 .
Likewise, Krt16 regulates early inflammation and innate immunity in skin 32 .
Krt76 is the most significantly downregulated gene encoding a structural protein in human OSCC 10, 34 and downregulation correlates strongly with poor prognosis 10 . We have found that Krt76-null mice exhibit a marked inflammatory disease phenotype with systemic components: splenomegaly and lymphadenopathy ( Figure 2 ). This is correlated with a significant expansion of B cells ( Supplementary Fig. 1c, d) , effector T cells and Tregs (Figure 3a, b) , as well as an upregulation of inflammatory cytokines (Figure 3c ).
The Krt76 -/-mouse serves as a model to explore the link between chronic inflammation and cancer, providing an opportunity to examine the impact of aberrant epithelial differentiation and consequent chronic inflammation on tumorigenesis. It is known that Krt76 -/-mice do not develop spontaneous tumour lesions in the oral mucosa 10 or skin. However, we have shown that in response to 4NQO treatment Krt76 -/-mice are more predisposed to developing tumours in those sites where Krt76 is normally expressed, namely the tongue and squamous stomach ( Figure   5f , g).
The enhanced sensitivity of Krt76 -/-mice to carcinogenesis was not due to defective epithelial barrier formation. In addition, although some of the effects of Krt17 are attributable to its nuclear location 6, 33 , we failed to detect nuclear Krt76 by antibody labelling and Krt76 is not predicted to have a nuclear localisation signal 35 . Instead the cancer susceptibility of Krt76 -/-mice correlated with a higher number of Tregs in secondary lymphoid organs and an enhanced accumulation of Tregs in the tongue and squamous stomach, which increased further in the tumour microenvironment (Figure 6e-h) . There was also a reduction in effector T cells in Krt76 -/-mice in the tumour microenvironment. We conclude that keratins not only regulate inflammation and immunity in the skin (reviewed in 3 ) but also in the oral cavity and squamous stomach.
Tregs were originally identified because of their ability to prevent organ-specific autoimmune disease by maintaining lymphocyte homeostasis and regulating activated T cells 20 . However, there is emerging evidence that they play a major role in the tumour microenvironment 20, 36 and contribute to tumour growth and progression by inhibiting the antitumor immune response 19, 26, 37 .
Increased numbers of FoxP3 + /CD25 + Tregs are observed in a subset of human OSCC and in the early stages of tumour progression in several mouse models 38 . While this has been linked to an immunosuppressive tumour microenvironment [39] [40] [41] [42] , there is still controversy about whether tumours with increased Tregs have a better or worse prognosis 43 .
Krt76 -/-mice exhibited deregulated cytokine expression. Anti-tumour function of dendritic cells is suppressed through IL-10 44 and we found IL-10 to be upregulated in Krt76 -/-mice, particularly after 4NQO treatment. Increased levels of IL-10 are also reported in patients with OSCC 45 . However, IL-6, which is a key cytokine in encouraging cancer cell proliferation 46 , was also upregulated in Krt76 -/-mice. After carcinogen treatment, we observed an increase in serum IFNγ (Figure 6a) , consistent with the fact that IL-18, which is also upregulated (Figure 6j ), stimulates IFNγ production 47 . Krt76 -/-effector T cells produced more IFNγ than control effector T cells in culture (cf. Figure 4d and Supplementary Fig. 2b ).
In addition to being more abundant, Tregs from Krt76 -/-mice had enhanced suppressive function, which correlated with higher levels of CD39 and CD73 expression ( Figure 4 ). CD39 is expressed on human and murine Tregs and is known to mediate immune T cell suppression by the downstream production of adenosine 48 . CD39 + Tregs suppress T cell proliferation more efficiently than CD39 -Tregs 22 . The coordinated expression of CD39 and CD73 on Tregs in Krt76 -/-mice can explain their enhanced suppressive function. Tregs from CD39 -/-mice have impaired suppressive function in vitro and fail to block transplant rejection in vivo 48 . Furthermore, Treg expression of CD39 and CD73 is greater in human HNSCC than in healthy tissue 49 , characterised by increased adenosine-mediated suppression of effector T cells 48, 49 .
In support of a positive role for Treg in 4NQO carcinogenesis, we found that partial depletion of donor Tregs in chimeric mice led to an increase in total Tregs and a corresponding acceleration of tumour formation, both in Krt76 -/-and control mice. We propose that upon loss of Krt76 the increase in the immunosuppressive Treg infiltrate leads to a failure in anti-tumour immunity linked to exaggerated suppression of anti-tumour-associated antigen-reactive lymphocytes. How loss of Krt76 exerts its effects requires further investigation; however, mechanisms involving inflammasome activation 50 or epithelial production of danger-associated molecular pattern (DAMP) proteins 51 are possibilities.
The inability to resolve chronic inflammation is considered one of the initial triggers of carcinogenesis 52 , while immunosuppression is a crucial tumour immune-evasion mechanism and the main obstacle to successful tumour immunotherapy 20 . Our study highlights the importance of keratins as immunomodulators and the potential significance of highly suppressive CD39 + Tregs in OSCC, making them potentially attractive targets for new cancer therapies. The Krt76 -/mouse provides a paradigm for understanding how the differentiated epithelial layers contribute to oral carcinogenesis by provoking both local and systemic immune responses 43 .
METHODS
Animal procedures
All animal procedures were subject to institutional ethical review and performed under the terms of a UK Home Office license. KRT76 -/-(Krt76 tm1a(KOMP)Wtsi ) mice were obtained from the Wellcome Trust Sanger Institute Mouse Genetics Project 13, 16, 17 . Heterozygous Krt76 +/-mice were crossed to obtain knockout (Krt76 -/-) and littermate control (heterozygous Krt76 +/-or wild type Krt76 +/+ ) mice. DEREG mice 31 were kindly provided by Caetano Reis e Sousa (The Francis Crick Institute). Mice were maintained on the C57Bl/6N genetic background.
In some experiments, mice received a dose of 500µg EdU (5-ethynyl-2'-deoxyuridine, Invitrogen) in PBS intraperitoneally 2h before tissues were harvested to assess proliferation. Tregs were depleted by intraperitoneal injection of 20ng diphtheria toxin (DTX; Sigma) per g mouse (as in Figure 8b ), once a week for 5 weeks 53 . Grafting efficiency was confirmed by analysing Foxp3 GFP + cells by flow cytometry at indicated time-points. Sample sizes were determined on the basis of prior power calculations.
Bone marrow reconstitution
In BM transplantation experiments, 8-to 16-week-old male and female Krt76 -/-and control littermate recipients (Krt76 +/-) were treated with acidified water at least 10 days before irradiation. Statistical power was calculated using the resource equation and animals were randomly assigned to treatment groups. Allogenic BM transplants were performed 24h after total body irradiation (two times 5.5 Gy, separated by 3 h). Donor BM was isolated from the tibia and femur of male mice. BM reconstitution was performed by intravenous injection of 2x10 6 BM cells in 200µl PBS. Chimerism was confirmed by analysing Foxp3GFP + cells in the blood by flow cytometry.
4NQO carcinogenesis
4NQO (Sigma, diluted to 100 µg/ml) was administered in the drinking water and fed to mice as the sole source of drinking water during the carcinogen-treatment period. 4NQO-containing water was prepared and changed once a week for 16 weeks. After that period, mice were given normal drinking water. During the experiments, the mice were maintained with regular mouse chow and water (with or without 4NQO) ad libitum. Once a week 4NQO-treated mice were sedated with inhaled isoflurane and the oral cavities were screened for lesions (hyperplasias, dysplasias and SCCs).
Flow cytometry
Lymph nodes, thymus and spleen were harvested from treated mice, mechanically disrupted, passed through a 40µm cell strainer (BD Falcon) and rinsed with PBS to remove debris. Red blood cells were lysed using Ammonium-Chloride-Potassium Lysing Buffer. Cell number was determined using a Scepter Cell Counter (Merck Millipore). Tongue and stomach tumours were Supplementary Fig. 4 .
Histology
For frozen sections, tissues were embedded in OCT (optimal cutting temperature compound), sectioned and post-fixed in 4% paraformaldehyde/PBS pH 7.4 for 10 min before staining. X-gal staining on frozen sections was performed as described 54 . The tissues were sectioned and stained with haematoxylin and eosin (H&E) and with Gram stain (Sigma) by conventional methods.
Images were acquired using a Hamamatsu slide scanner and analysed using NanoZoomer software (Hamamatsu).
Immunofluorescence staining
Frozen sections were fixed in 2% paraformaldehyde/PBS pH 7.4 and blocked with 10% goat serum, 2% BSA, 0.02% fish skin gelatin and 0.05% TritonX100 (Sigma) in PBS for 1h at room temperature. Paraffin sections of human OSCC were subjected to heat-mediated antigen retrieval (citrate buffer, pH6) prior to blocking. Primary antibodies were incubated overnight at 4°C, followed by 1h incubation at room temperature in secondary antibody.
The following primary antibodies were used: Foxp3 (eBioscience, clone FJK-16s, 1/100, and Abcam, clone 236A/E7, 1/50), anti-Loricrin, anti-Krt76 (Santa Cruz, clone F-12, 1/100, and Sigma, HPA019656, 1/100), Krt14 (Covance, PRB-155P, 1/1000), B220/CD45R (eBioscience, clone RA3-6B2, 1/100), CD3 (BD Pharmingen, clone 17A2, 1/150), CD45 (BD Pharmingen clone 30-F11, 1/150); and secondary antibodies: anti-goat, anti-mouse and anti-rabbit Alexa Fluor 488, 568 and 633 (Life Technologies, 1/300).
EdU staining was performed with a Click-it EdU imaging kit (Life Technologies) according to the manufacturer's recommendations. DAPI (Life Technologies) was used as a nuclear counterstain. Slides were mounted using ProLong Gold anti-fade reagent (Life Technologies).
Images were acquired with a Nikon A1 Upright Confocal microscope. Images were analysed using ICY software.
Quantification of cell number and epithelial thickness
Images were quantified using open-source ICY software plug-in Manual Counting 55 . Positively stained cells for CD45, EdU or Foxp3 were counted per length of the epithelium analysed or per stromal area (as delineated in Figure 3 ). The total number of nuclei was quantified using DAPI staining. All cell count analyses were performed using sequential sections from well-oriented tongue or stomach blocks in a blind manner on an average of 10 independent fields per animal (n=3-6 animals/genotype/experiment). Representative images from two to three independent experiments with at least three biological replicates per group are shown. All statistical analyses were carried out using Prism 7 (Graph Pad).
Fluorescence in-situ hybridisation with BacUni
Pieces of tongue and stomach epithelia were collected and sectioned in a sterilized setup.
Sections were fixed in 1:1 acetone-to-methanol and incubated with PNA FISH probes at 55°C. A universal bacteria probe (BacUni; AdvanDx) and probe for C. dubuliniensis (AdvanDx) were used 25 . DAPI was used for nuclear counterstaining. Slides were mounted using ProLong Gold anti-fade reagent (Life Technologies). Images and Z-stacks were acquired with a Nikon A1 Upright Confocal microscope. Evaluation of bacterial location was performed on threedimensional z-stacks using ICY software.
Epithelial permeability assays
Whole embryos or dissected tongues were dehydrated through a methanol series (25%, 50%, 75%, and 100% methanol, 60 s per step), rehydrated in PBS, and then stained immediately with 0.1% toluidine blue in water for 10 min, with agitation at room temperature. Samples were briefly washed in PBS and immediately photographed using a Nikon SWZ18 and Nikon DS-Ri2 camera.
Stomach barrier function was assessed using a FITC-labelled dextran method. Briefly, food and water were withdrawn for 4h and mice were sedated with inhaled isoflurane and orally administrated with the permeability tracer by oral gavage (60 mg/100 g body weight of FITClabelled dextran, MW 4000; FD4, Sigma-Aldrich). After 30min, blood was collected by cardiac puncture into Microtainer SST tubes and fluorescence intensity was determined using GloMax® Discover Multimode Microplate Reader (Promega; excitation, 492 nm; emission, 525 nm). FITCdextran concentrations were determined using a standard curve generated by serial dilution of FITC-dextran. 
Tissue collection, RNA extraction and gene-expression analysis
Cytokine analysis by cytometric bead array multiplex assays
Blood was collected by cardiac puncture and left to clot for 2h. Serum was collected after centrifugation for 20 min at 4°C. Supernatants from the suppressions assays were collected and kept at -80ºC prior to analysis. Levels of IFNγ, IL-2, IL-4, IL-6, IL-10 and TNFα were analysed in the serum or in cell culture supernatants using a mouse cytometric bead array Th1/Th2/ Th17 cytokine kit (BD Biosciences) following the manufacturer's instructions. Data were acquired using the BD FACSCanto system (BD Biosciences) and analysed using FlowJo software. All samples were measured in technical duplicates and biological replicates (n=4 for each group).
Statistical analysis
All graphs and statistical calculations were generated using Prism7 (GraphPad) software. 
